High Vista Strategies LLC Axsome Therapeutics, Inc. Transaction History

High Vista Strategies LLC

$242 Million
Q4 2024

A detailed history of High Vista Strategies LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 17,124 shares of AXSM stock, worth $2.21 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

17,124

Previous 41,542 58.78%

Holding current value

$2.21 Million

Previous $3.73 Million 61.2%

% of portfolio

0.6%

Previous 1.46%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $2.03 Million - $2.45 Million	-24,418 Reduced 58.78%	17,124 $1.45 Million
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $1.63 Million - $1.98 Million	-20,650 Reduced 33.2%	41,542 $3.73 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $898,063 - $1.1 Million	13,665 Added 28.16%	62,192 $5.01 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $953,141 - $1.34 Million	-13,736 Reduced 22.06%	48,527 $3.87 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $304,268 - $443,049	5,299 Added 9.3%	62,263 $4.96 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $523,807 - $621,836	7,564 Added 15.31%	56,964 $3.98 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $664,355 - $1.03 Million	-11,374 Reduced 18.72%	49,400 $3.55 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $329,903 - $423,750	5,650 Added 10.25%	60,774 $3.75 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.53 Million - $3.05 Million	38,238 Added 226.45%	55,124 $4.25 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $608,909 - $1.18 Million	16,886 New	16,886 $753,000
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $590,548 - $857,304	-11,664 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $36,397 - $53,017	651 Added 5.91%	11,664 $660,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $331,616 - $432,686	5,001 Added 83.18%	11,013 $897,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $63,487 - $79,745	-929 Reduced 13.38%	6,012 $428,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $346,147 - $685,007	6,941 New	6,941 $571,000

Others Institutions Holding AXSM

# of Institutions

351

Shares Held

36.3M

Call Options Held

1.77M

Put Options Held

1.16M

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.54B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Account

High Vista Strategies LLC Axsome Therapeutics, Inc. Transaction History